Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study

BACKGROUND: Secondary prevention of atrial fibrillation (AF) could be carried out by means of antiarrhythmic drugs; however this strategy has not received any endorsement because these drugs are burdened by a high risk of proarrhythmic events (flecainide, sotalol) or extracardiac effects (amiodarone...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vecchis, Renato, Paccone, Andrea, Di Maio, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681845/
https://www.ncbi.nlm.nih.gov/pubmed/31413779
http://dx.doi.org/10.14740/cr909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681845/
https://www.ncbi.nlm.nih.gov/pubmed/31413779
http://dx.doi.org/10.14740/cr909

Ejemplares similares